PELL Bio-Med Technology Co. Ltd. (6949.TW)

TWD 122.5

(-2.39%)

Total Assets Summary of PELL Bio-Med Technology Co. Ltd.

  • PELL Bio-Med Technology Co. Ltd.'s latest annual total assets in 2023 was 1.41 Billion TWD , up 35.79% from previous year.
  • PELL Bio-Med Technology Co. Ltd.'s latest quarterly total assets in 2024 Q2 was 1.8 Billion TWD , up 9.16% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported annual total assets of 1.04 Billion TWD in 2022, up 165.15% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported annual total assets of 393.88 Million TWD in 2021, down 0.0% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported quarterly total assets of 1.8 Billion TWD for 2024 Q2, up 9.16% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported quarterly total assets of 1.41 Billion TWD for 2023 Q4, up 58.85% from previous quarter.

Annual Total Assets Chart of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Historical Annual Total Assets of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Year Total Assets Total Assets Growth
2023 1.41 Billion TWD 35.79%
2022 1.04 Billion TWD 165.15%
2021 393.88 Million TWD 0.0%

Peer Total Assets Comparison of PELL Bio-Med Technology Co. Ltd.

Name Total Assets Total Assets Difference
Apex Biotechnology Corp. 2.29 Billion TWD 38.261%
Sinphar Pharmaceutical Co.,Ltd. 6.25 Billion TWD 77.313%
Panion & Bf Biotech Inc. 3.23 Billion TWD 56.165%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 5.17 Billion TWD 72.578%
GenMont Biotech Incorporation 1.65 Billion TWD 14.217%
Abnova (Taiwan) Corporation 1.35 Billion TWD -4.604%
Adimmune Corporation 9.48 Billion TWD 85.048%
Tanvex BioPharma, Inc. 2.76 Billion TWD 48.681%
Polaris Group 9.09 Billion TWD 84.412%
Energenesis Biomedical CO.,LTD. 828.57 Million TWD -71.157%
UnicoCell Biomed Co., Ltd. 685.92 Million TWD -106.75%